Gene therapy shows early promise for treating obesity (EurekAlert!)
( Ohio State University Medical Center ) With obesity reaching epidemic levels, researchers at the Ohio State University Medical Center are studying a potentially long-term treatment that involves injecting a gene directly into one of the critical feeding and weight control centers of the brain.

European Commission And United States Food And Drug Administration (FDA) Both Approve New Options For Patients With ... (Medical News Today)
Schering-Plough Corporation (NYSE: SGP) announced that the European Commission and the US FDA both approved the intravenous (IV) formulation of temozolomide as an alternative to the already approved oral form of the drug. Temozolomide is marketed as TEMODAL(R) in the EU and as TEMODAR(R) in the US.